Li et al. indicated that KIF20A silencing significantly impaired the proliferative and invasive capabilities of ovarian cancer cells, and FOXO1 could target KIF20A to manipulate cellular behaviors (Li et al., 2020). Here, FOXO1 is linked to ovarian cancer.